HeartX Webinar Series: Emerging Innovation in Atrial Fibrillation Care, Rhythm Monitoring and Electrophysiology

Webinar Description

Take an exclusive look at emerging cardiovascular innovation from the 2025 HeartX cohort, MedAxiom and HealthTech Arkansas’s accelerator focused on supporting early-stage companies advancing cardiovascular care.

This session features:

StimCardio Medical is pioneering a non-invasive therapy for atrial fibrillation through a wearable device that combines proprietary neuromodulation with AI-powered cardiac rhythm monitoring to support personalized management at home.

CathVision will highlight its ECGenius system, which delivers high-fidelity, noise-cancelling cardiac signals to support ablation decisions. Its technology also provides real-time tissue feedback during pulsed field ablation and identifies focal AFib drivers to help guide more precise interventions.

FibriCheck will showcase its FDA-cleared platform for remote AFib detection and monitoring, using smartphone-based assessments and AI-powered reporting to support clinical workflows, informed decision-making, and expanded access to at-home rhythm monitoring.

Speakers

Margaux Casteur, Director of US Growth, FibriCheck
Michael Iversen, Commercial Strategy, CathVision
Amir Soltanianzadeh, CEO, StimCardio

Summary

Availability:

Registration Required
(974 seats available)

Location:

Online Meeting

Date / Time:

Jun 02, 2026 1:00 PM - 2:00 PM ET

Cost:

FREE

Credit Offered:

No Credit Offered